NCT05238623View on ClinicalTrials.gov

Imbalances of Regional Pulmonary Ventilation in Patients With Post-acute-COVID-19

Not yet recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

March 31, 2027

Conditions
COVID-19 PneumoniaPost-acute COVID-19 SyndromeElectric Impedance
Interventions
DIAGNOSTIC_TEST

additional EIT Measurement

Patients who receive standard CT and pulmonary function testing also receive electroimpedance tomography measurement. The lunghealthy Patients in the control group only receive a EIT.

Trial Locations (1)

07747

Klinik für Notfallmedizin, Jena

All Listed Sponsors
lead

Jan-Christoph Lewejohann

OTHER

NCT05238623 - Imbalances of Regional Pulmonary Ventilation in Patients With Post-acute-COVID-19 | Biotech Hunter | Biotech Hunter